Antidiabetic, lipid normalizing, and nephroprotective actions of the strawberry: A potent supplementary fruit

International Journal of Molecular Sciences

Volumn 18, Issue 1, 2017, Pages

  Mandave, Pallavi ^a   Khadke, Suresh ^a   Karandikar, Manjiri ^b   Pandit, Vijaya ^b   Ranjekar, Prabhakar ^a   Kuvalekar, Aniket ^a   Mantri, Nitin ^c  

^a Bharati Vidyapeeth   (India)

^b Bharati Vidyapeeth's Medical College   (India)

^c RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COA CARBOXYLASE ALPHA; ACYL COENZYME A SYNTHETASE LONG CHAIN 1; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MALONYL COA ACYL CARRIER PROTEIN TRANSACYLASE; PEPTIDES AND PROTEINS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN; STRAWBERRY EXTRACT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ANTIDIABETIC AGENT; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID; PROTECTIVE AGENT;

ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER FUNCTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; STRAWBERRY; WEIGHT REDUCTION; ANIMAL; BLOOD; CHEMISTRY; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FRAGARIA; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; LIPID METABOLISM; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FRAGARIA; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; INFLAMMATION MEDIATORS; KIDNEY; LIPID METABOLISM; LIPIDS; LIVER; MALE; OXIDATION-REDUCTION; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS;

EID: 85009823874     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18010124     Document Type: Article

References (80)

1. Georg, P.; Ludvik, B. Lipids and diabetes. J. Clin. Basic Cardiol. 2000, 3,159-162. Nyholm, B.; Porksen, N.; Juhl, C.B.; Gravholt, C.H.; Butler, P.C.; Weeke, J.; Veldhuis, J.D.; Pincus, S.; Schmitz, O. Assessment of insulin secretion in relatives of patients with type2 (non-insulin-dependent) diabetes mellitus: Evidence of early |3-cell dysfunction. Metabolism 2000, 49, 896-905. [CrossRef] [PubMed]
2. Yajnik, C.S. The insulin resistance epidemic in India: Fetal origins, later lifestyle, or both? Nutr. Rev. 2001, 59,1-9. [CrossRef] [PubMed]
3. Srinivasan, K.; Ramarao, P. Animal models in type 2 diabetes research: An overview. Indian J. Med. Res. 2007, 125, 451-472. [PubMed]
4. Bantle, J.P.; Wylie-Rosett, J.; Albright, A.L.; Apovian, C.M.; Clark, N.G.; Franz, M.J.; Hoogwerf, B.J.; Lichtenstein, A.H.; Mayer-Davis, E.; Mooradian, A.D.; et al. Nutrition recommendations and interventions for diabetes: A position statement of the american diabetes association. Diabetes Care 2008, 31, 61-78.
5. Franz, M.J.; Powers, M.A.; Leontos, C.; Holzmeister, L.A.; Kulkarni, K.; Monk, A.; Wedel, N.; Gradwell, E. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J. Am. Diet. Assoc. 2010, 110,1852-1889. [CrossRef] [PubMed]
6. Morris, S.F.; Wylie-Rosett, J. Medical nutrition therapy: A key to diabetes management and prevention. Clin. Diabetes 2010, 28,12-18. [CrossRef]
7. Mann, J.I.; de Leeuw, I.; Hermansen, K.; Karamanos, B.; Karlstrom, B.; Katsilambros, N.; Riccardi, G.; Rivellese, A.A.; Rizkalla, S.; Slama, G.; et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2004,14, 373-394. [CrossRef]
8. Feeney, M.J. Fruits and the prevention of lifestyle-related diseases. Clin. Exp. Pharmacol. Physiol. 2004, 11-13. [CrossRef] [PubMed]
9. Chong, M.F.; Macdonald, R.; Lovegrove, J.A. Fruit polyphenols and CVD risk: A review of human intervention studies. Br. J. Nutr. 2010,104, 28-39. [CrossRef] [PubMed]
10. Gonzalez-Gallego, J.; Garcia-Mediavilla, M.V.; Sanchez-Campos, S.; Tunon, M.J. Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2010,104,15-27. [CrossRef] [PubMed]
11. Dauchet, L.; Amouyel, P.; Hercberg, S.; Dallongeville, J. Fruit and vegetable consumption and risk of coronary heart disease: A meta-analysis of cohort studies. J. Nutr. 2006,136, 2588-2593. [PubMed]
12. Martinez-Gonzalez, M.A.; Lamuela-Raventos, R.M. The unparalleled benefits of fruit. Br. J. Nutr. 2009, 102, 947-948. [CrossRef] [PubMed]
13. Aune, D.; Lau, R.; Chan, D.S.; Vieira, R.; Greenwood, D.C.; Kampman, E.; Norat, T. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011,141,106-118. [CrossRef] [PubMed]
14. Tulipani, S.; Alvarez-Suarez, J.M.; Busco, F.; Bompadre, S.; Quiles, J.L.; Mezzetti, B.; Battino, M. Strawberry consumption improves plasma antioxidant status and erythrocyte resistance to oxidative haemolysis in humans. Food Chem. 2011,128, 180-183. [CrossRef] [PubMed]
15. Silva, F.L.; Pascual-Teresa, S.; Rivas-Gonzalo, J.C.; Santos-Buelga, C. Identification of anthocyanin pigments in strawberry (cv. Camarosa.) by LC using DAD and ESI-MS detection. Eur. Food Res. Technol. 2002, 214, 248-253. [CrossRef]
16. Seeram, N.P.; Lee, R.; Scheuller, H.S.; Heber, D. Identification of phenolic compounds in strawberries by liquid chromatography electrospray ionization mass spectrometry. Food Chem. 2006, 97,1-11. [CrossRef]
17. Pinto, M.D.S.; Carvalho, J.E.D.; Lajolo, F.M.; Genovese, M.I.; Shetty, K. Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria x ananassa Duch.) using in vitro models. J. Med. Food 2010,13,1027-1035. [CrossRef] [PubMed]
18. Cao, G.; Russell, R.M.; Lischner, N.; Prior, R. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J. Nutr. 1998,128, 2383-2390. [PubMed]
19. Miyazawa, T.; Nakagawa, K.; Kudo, M.; Muraishi, K.; Someya, K. Direct intestinal absorption of red fruit anthocyanins, Cyanidin-3-glucoside and Cyanidin-3,5-diglucoside, into rats and humans. J. Agric. Food Chem. 1999, 47, 1083-1091. [CrossRef] [PubMed]
20. Matsumoto, M.; Hara, H.; Chiji, H.; Kasai, K. Gastroprotective effect of red pigments in black chokeberry fruit (Aronia. melanocarpa Elliot) on acute gastric hemorrhagic lesions in rats. J. Agric. Food Chem. 2004, 2226-2229. [CrossRef] [PubMed]
21. Hwan, P.B.; Khanal, T.; Choi, J.M.; Chung, Y.C.; Jeong, H.G. Anthocyanins from purple sweet potato attenuate dimethylnitrosamine-induced liver injury in rats by inducing Nrf2-mediated antioxidant enzymes and reducing COX-2 and iNOS expression. Food Chem. Toxicol. 2011, 49, 93-99. [CrossRef] [PubMed]
22. Wang, S.Y.; Jiao, H. Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J. Agric. Food Chem. 2000, 48, 5677-5684. [CrossRef] [PubMed]
23. Chang, W.C.; Yu, Y.M.; Chiang, S.Y.; Tseng, C.Y. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: Studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br. J. Nutr. 2008, 99, 709-714. [CrossRef] [PubMed]
24. Yu, Y.M.; Chang, W.C.; Wu, C.H.; Chiang, S.Y. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J. Nutr. Biochem. 2005,16, 675-681. [CrossRef] [PubMed]
25. Wolfe, K.L.; Kang, X.; He, X.; Dong, M.; Zhang, Q.; Liu, R.H. Cellular antioxidant activity of common fruits. J. Agric. Food Chem. 2008, 56, 8418-8426. [CrossRef] [PubMed]
26. Pinto, M.D.S.; Kwon, Y.I.; Apostolidis, E.; Lajolo, F.M.; Genovese, M.I.; Shetty, K. Functionality of bioactive compounds in Brazilian strawberry (Fragariax ananassa Duch.) cultivars: Evaluation of hyperglycemia and hypertension potential using in vitro models. J. Agric. Food Chem. 2008, 56, 4386-4392.
27. Pinto, M.D.S.; Kwon, Y.I.; Apostolidis, E.; Lajolo, F.M.; Genovese, M.I.; Shetty, K. Functionality of bioactive compounds in Brazilian strawberry (Fragariax ananassa Duch.) cultivars: Evaluation of hyperglycemia and hypertension potential using in vitro models. J. Agric. Food Chem. 2008, 56, 4386-4392
28. Prior, R.L.; Wu, X.; Gu, L.; Hager, T.J.; Hager, A.; Howard, L.R. Whole berries versus berry anthocyanins: Interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J. Agric. Food Chem. 2008, 647-653. [CrossRef] [PubMed]
29. Tsuda, T.; Ueno, Y.; Aoki, H.; Koda, T.; Horio, F.; Takahashi, N.; Kawada, T.; Osawa, T. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 2004, 316,149-157. [CrossRef] [PubMed]
30. Abdulazeez, S.S. Effects of freeze-dried Fragaria x ananassa powder on alloxan-induced diabetic complications in Wistar rats. J. Taibah Univ. Med. Sci. 2014, 9, 268-273. [CrossRef]
31. Abdulazeez, S.S. Freeze dried strawberry powder ameliorates alloxan induced hyperlipidemia in diabetic rats. Biomed. Res. 2015,26, 77-81.
32. Chebil, L.; Humeau, C.; Anthoni, J.; Dehez, F.; Engasser, J.; Ghoul, M. Solubility of flavonoids in organic solvents. J. Chem. Eng. Data 2007, 52,1552-1556. [CrossRef]
33. Ferreira, O.; Pinho, S.P. Solubility of flavonoids in pure solvents. Ind. Eng. Chem. Res. 2012, 51, 6586-6590. [CrossRef]
34. Mandave, P.; Rani, S.; Kuvalekar, A.; Ranjekar, P. Antiglycation, antioxidant and antidiabetic activity of mature strawberry (Fragariax ananassa Duch.) fruits. Int. J. Appl. Biol. Pharm. 2013, 4,168-177.
35. Mandave, P.C.; Pawar, P.K.; Ranjekar, P.K.; Mantri, N.; Kuvalekar, A.A. Comprehensive evaluation of in vitro antioxidant activity, total phenols and chemical profiles of two commercially important strawberry varieties. Sci. Hort. 2014,172,124-134. [CrossRef]
36. Rani, S.; Mandave, P.; Kuvalekar, A.; Ranjekar, P. Antiglycation, antioxidant and antidiabetic activity of strawberry (Fragariax ananassa Duch.) fruits during ripening stages. Res. J. Pharm. Biol. Chem. Sci. 2014, 5,193-203.
37. Kumawat, M.; Sharma, T.K.; Singh, I.; Singh, N.; Ghalaut, V.S.; Vardey, S.K.; Shankar, V. Antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus patients with and without nephropathy. N. Am. J. Med. Sci. 2013, 5, 213-219. [PubMed]
38. Naderi, R.; Mohaddes, G.; Mohammadi, M.; Ghaznavi, R.; Ghyasi, R.; Vatankhah, A.M. Voluntary exercise protects heart from oxidative stress in diabetic rats. Adv. Pharm. Bull. 2015, 5, 231-236. [CrossRef] [PubMed]
39. Kochar, N.I.; Umathe, S.N. Beneficial effects of L-arginine against diabetes-induced oxidative stress in gastrointestinal tissues in rats. Pharmacol. Rep. 2009, 61, 665-672. [CrossRef]
40. Zelen, I.; Djurdjevic, P.; Popovic, S.; Stojanovic, M.; Jakovljevic, V.; Radivojevic, S.; Baskic, D.; Arsenijevic, N. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients. J. BUON 2010,15, 330-336. [PubMed]
41. Mandave, P.M.; Khadke, S.; Karandikar, M.; Pandit, V.; Ranjekar, P.; Kuvalekar, A.; Mantri, N.; Interactive Research School for Health Affairs, Bharati Vidyapeeth University, Katraj, Pune, Maharashtra, India. Hematoxylin- and eosin-stained cross sections of paraffin-embedded brain and liver tissues of rats from control and experimental groups. Unpublished work, 2017.
42. Basu, A.; Wilkinson, M.; Penugonda, K.; Simmons, B.; Betts, N.M.; Lyons, T.J. Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: Baseline and post intervention effects. Nutr. J. 2009, 8, 43. [CrossRef] [PubMed]
43. Pieszka, M.; Tombarkiewicz, B.; Roman, A.; Migdal, W.; Niedziolka, J. Effect of bioactive substances found in rapeseed, raspberry and strawberry seed oils on blood lipid profile and selected parameters of oxidative status in rats. Environ. Toxicol. Pharmacol. 2013, 36,1055-1062.[CrossRef] [PubMed]
44. Jaroslawska, J.; Juskiewicz, J.; Wroblewska, M.; Jurgonski, A.; Krol, B.; Zdunczyk, Z. Polyphenol-rich strawberry pomace reduces serum and liver lipids and alters gastrointestinal metabolite formation in fructose-fed rats. J. Nutr. 2011,141,1777-1783. [CrossRef] [PubMed]
45. Fadri, R.A.; Rilma, N.; Fadil, O.; Kesuma, S. The mixture of yogurt and strawberry juice to repair blood lipid profile. Int. J. Adv. Sci. Eng. Inf. Technol. 2014, 4,137-139.
46. Basu, A.; Michael, R.; Timothy, J.L. Berries: Emerging impact on cardiovascular health. Nutr. Rev. 2010, 168-177. [CrossRef] [PubMed]
47. Sun, J.; Chu, Y.F.; Wu, X.; Liu, R.H. Antioxidant and antiproliferative activities of common fruits. J. Agric. Food Chem. 2002, 50, 7449-7454. [CrossRef] [PubMed]
48. Hung, H.C.; Joshipura, K.J.; Jiang, R.; Hu, F.B.; Hunter, D.; Smith-Warner, S.A.; Colditz, G.A.; Rosner, B.; Spiegelman, D.; Willett, W.C. Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst. 2004, 96,1577-1584. [CrossRef] [PubMed]
49. Erlund, I.; Riitta, F.; Jukka, M.; Paula, H.; Georg, A. Bioavailability of quercetin from berries and the diet. Nutr. Cancer 2006, 54,13-17. [CrossRef] [PubMed]
50. Maria, R.W.; Maria, E.P.; Daniel, R.G. Ellagic acid content in strawberries of different cultivars and ripening stages. J. Sci. Food Agric. 2003, 83, 842-845.
51. Pinto, M.D.S.; Franco, M.L.; Genovese, M.I. Bioactive compounds and quantification of total ellagic acid in strawberries (Fragaria x ananassa Duch.). Food Chem. 2008,107,1629-1635. [CrossRef]
52. Maher, P.; Dargusch, R.; Ehren, J.L.; Okada, S.; Sharma, K.; Schubert, D. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS ONE 2011, 6, e21226. [CrossRef] [PubMed]
53. Keller, H.; Wahli, W. Peroxisome proliferator-activated receptors—A link between endocrinology and nutrition? Trends Endocrinol. Metab. 1993, 4, 291-296. [CrossRef]
54. Schoonjans, K.; Staels, B.; Auwerx, J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1996, 1302, 93-109. [CrossRef]
55. Horton, J.D.; Goldstein, J.L.; Brown, M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. Eur. J. Clin. Investig. 2002,109,1125-1131. [CrossRef]
56. Shimomura, I.; Bashmakov, Y.; Horton, J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 1999, 274, 30028-30032. [CrossRef] [PubMed]
57. Moon, Y.A.; Liang, G.; Xie, X.; Frank-Kamenetsky, M.; Fitzgerald, K.; Koteliansky, V.; Brown, M.S.; Goldstein, J.L.; Horton, J.D. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012,15, 240-246. [CrossRef] [PubMed]
58. Yuan, M.; Konstantopoulos, N.; Lee, J.; Hansen, L.; Li, Z.W.; Karin, M.; Shoelson, S.E. Reversal of obesity and diet induced insulin resistance with salicylates or targeted disruption of IKK-|3. Science 2001, 293,1673-1677. [CrossRef] [PubMed]
59. Arkan, M.C.; Hevener, A.L.; Greten, F.R.; Maeda, S.; Li, Z.W.; Long, J.M.; Wynshaw-Boris, A.; Poli, G.; Olefsky, J.; Karin, M. IKK-|3links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 191-198. [CrossRef] [PubMed]
60. Cai, D.; Yuan, M.; Frantz, D.F.; Melendez, P.A.; Hansen, L.; Lee, J.; Shoelson, S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-|3 and NF-efi. Nat. Med. 2005,11, 183-190. [CrossRef] [PubMed]
61. Randle, P.J.; Garland, P.B.; Hales, C.N.; Newsholme, E.A. The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963,1, 785-789. [CrossRef]
62. Houten, S.M.; Wanders, R.J.A. A general introduction to the biochemistry of mitochondrial fatty acid P-oxidation. J. Inherit. Metab. Dis. 2010, 33, 469-477. [CrossRef] [PubMed]
63. George, A.; Fahey, T.; Baldwin, K. Exercise Physiology: Human Bioenergetics and Its Applications, 4th ed.; McGraw-Hill Education: Boston, MA, USA, 2004.
64. Furuta, E.; Pai, S.K.; Zhan, R.; Bandyopadhyay, S.; Watabe, M.; Mo, Y.Y.; Hirota, S.; Hosobe, S.; Tsukada, T.; Miura, K.; et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008, 68, 1003-1011. [CrossRef] [PubMed]
65. Wu, M.; Singh, S.B.; Wang, J.; Chung, C.C.; Salituro, G.; Karanam, B.V.; Lee, S.H.; Powles, M.; Ellsworth, K.P.; Lassman, M.E.; et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc. Natl. Acad. Sci. USA 2011, 108, 5378-5383. [CrossRef] [PubMed]
66. Radenne, A.; Akpa, M.; Martel, C.; Sawadogo, S.; Mauvoisin, D.; Mounier, C. Hepatic regulation of fatty acid synthase by insulin and T3: Evidence for T3 genomic and nongenomic actions. Am. J. Physiol. Endocrinol. Metab. 2008, 295, 884-894. [CrossRef] [PubMed]
67. Montoudis, A.; Seidman, E.; Boudreau, F.; Beaulieu, J.F.; Menard, D.; Elchebly, M.; Mailhot, G.; Sane, A.T.; Lambert, M.; Delvin, E.; et al. Intestinal fatty acid binding protein regulates mitochondrion p-oxidation and cholesterol uptake. J. Lipid Res. 2008,49,961-972. [CrossRef] [PubMed]
68. Smathers, R.L.; Petersen, D.R. The human fatty acid-binding protein family: Evolutionary divergences and functions. Hum. Genom. 2011, 5,170-191. [CrossRef]
69. Hisanaga, Y.; Ago, H.; Nakagawa, N.; Hamada, K.; Ida, K.; Yamamoto, M.; Hori, T.; Arii, Y.; Sugahara, M.; Kuramitsu, S.; et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J. Biol. Chem. 2004,279, 31717-31726. [CrossRef] [PubMed]
70. Sharma, S.; Black, S.M. Carnitine homeostasis, mitochondrial function, and cardiovascular disease. Drug Discov. Today Dis. Mech. 2009, 6, 31-39. [CrossRef] [PubMed]
71. Feingold, K.R.; Soued, M.; Staprans, I.; Gavin, L.A.; Donahue, M.E.; Huang, B.J.; Moser, A.H.; Gulli, R.; Grunfeld, C. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J. Clin. Investig. 1989, 83, 1116-1121. [CrossRef] [PubMed]
72. Fon, T.K.; Kuzman, D.; Seliskar, M.; Pompon, D.; Rozman, D. TNF-a interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol. Genom. 2007,31,216-227.
73. Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocins—A viable alternative to antibiotics? Nat. Rev. Microbiol. 2013, 95-105. [CrossRef] [PubMed]
74. Roberts, L.D.; Murray, A.J.; Menassa, D.; Ashmore, T.; Nicholls, A.W.; Griffin, J.L. The contrasting roles of PPAR-5 and PPAR-y in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol. 2011,12, 75-94. [CrossRef] [PubMed]
75. Friedewald, W.T.; Levy, R.I.; Fredrickso, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502. [PubMed]
76. Warnick, G.R.; Knopp, R.H.; Fitzpatrick, V.; Branson, L. Estimating low-density lipoprotein cholesterol by the friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem. 1990,36,15-19. [PubMed]
77. Bradford, M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254. [CrossRef]
78. Buege, J.A.; Aust, S.D. Microsomal lipid peroxidation methods. Enzymology 1978,52,302-310.
79. Goth, L.; Nemeth, H.; Meszaros, I. Serum catalase activity for detection of hemolytic diseases. Clin. Chem. 1983, 29, 741-743. [PubMed]
80. Campbell, J.E.; Oh, T.; Hurtgen, B.J.; Niemeyer, D.M.; Sheppard, F.R.; Lucca, J.J.D. Blast overpressure induced pulmonary and intestinal damage is ameliorated by post-injury decay accelerating factor injection. J. Clin. Immunol. Immunother. 2015, 2,1-6.